recent
zika
viru
zikv
outbreak
mainli
affect
brazil
neighbour
state
demonstr
pauciti
inform
concern
epidemiolog
sever
flavirus
also
highlight
lack
avail
agent
treat
emerg
diseas
show
heparin
wide
use
anticoagul
exert
modest
inhibitori
effect
zika
viru
replic
fulli
prevent
virusinduc
cell
death
human
neural
progenitor
cell
npc
zika
viru
zikv
member
flaviviridea
famili
compris
ca
virus
share
common
structur
featur
take
name
zika
forest
uganda
first
isol
dick
dick
et
al
caus
agent
emerg
infect
aris
bite
aed
aegypti
speci
yet
full
implic
human
health
remain
unclear
widespread
infect
seriou
birth
defect
includ
neurolog
diseas
microcephali
brazil
report
rasmussen
et
al
adult
zikv
infect
link
epidemiolog
increas
preval
guillainbarr
e
syndrom
caolormeau
et
al
parra
et
al
thu
utero
adult
zikvassoci
patholog
condit
suggest
viru
could
infect
nerv
bell
et
al
neural
cell
garcez
et
al
addit
mode
transmiss
mosquito
bite
also
emerg
includ
sexual
transmiss
dortenzio
et
al
foy
et
al
musso
et
al
blood
transfus
motta
et
al
could
expand
epidem
impact
zikv
infect
increas
need
effect
vaccin
antivir
agent
treat
infect
individu
convent
antivir
drugdiscoveri
pipelin
involv
complex
expens
timeconsum
process
milit
rapid
widespread
deploy
particularli
develop
countri
one
attract
altern
combat
emerg
rapidli
spread
infecti
diseas
drug
repurpos
cheng
et
al
applic
exist
licens
pharmaceut
agent
anoth
medic
need
alreadi
propos
treatment
hepat
c
et
al
ebola
viru
sakurai
et
al
infect
heparin
wide
use
anticoagul
potenti
attract
featur
includ
activ
attach
entri
envelop
virus
human
simplex
hsv
herold
et
al
nahmia
kibrick
human
immunodefici
hiv
baba
et
al
sar
coronaviru
vicenzi
et
al
influenza
explor
effect
heparin
zikv
infect
human
neural
progenitor
cell
hnpc
particular
regard
viru
replic
induct
cytopath
effect
cpe
result
cell
death
human
neural
progenitor
cell
hnpc
obtain
reprogram
human
adult
skin
fibroblast
movement
disord
biobank
carlo
besta
institut
milan
itali
reprogram
cytotuneip
sendai
kit
life
technolog
obtain
human
induc
pluripot
stem
cell
hipsc
maintain
feederfre
condit
cultur
medium
stem
cell
technolog
report
orellana
et
al
embryoid
bodi
eb
dissoci
hipsc
seed
lowadhes
plate
medium
supplement
thermofish
scientif
human
noggin
mgml
r
system
mm
sigma
mm
miltenyi
biotec
penicillinstreptomycin
mgml
sigma
rosett
eb
plate
day
onto
matrigelco
plate
matrigel
growth
factor
reduc
corn
sigma
nonessenti
amino
acid
thermofish
scientif
penicillinstreptomycin
day
cell
passag
accutas
sigma
seed
matrigel
coatedflask
media
contain
thermofish
scientif
penicillinstreptomycin
basic
fibroblast
growth
factor
ngml
thermofish
scientif
virus
employ
histor
zikv
strain
evag
european
viru
archiv
recent
brazilian
strain
genbank
access
isol
italian
citizen
travel
brazil
januari
viral
strain
infect
hnpc
strain
middl
two
panel
without
upper
two
panel
heparin
treatment
mgml
determin
cell
bona
fide
hnpc
cell
stain
red
nestin
green
hoechst
blue
uninfect
infect
cell
fix
day
paraformaldehyd
solut
stain
mab
specif
flaviviru
e
protein
green
pb
wash
cell
wash
mount
examin
microscopi
quantif
infect
effici
viral
titer
releas
cultur
supernat
report
two
lower
panel
left
right
respect
scale
bar
upper
left
panel
mm
scale
bar
remain
panel
mm
bar
graph
indic
mean
sem
independ
experi
p
valu
calcul
student
pair
ttest
b
infect
hnpc
strain
middl
two
panel
without
upper
panel
heparin
treatment
mgml
uninfect
infect
cell
fix
day
paraformaldehyd
solut
stain
mab
specif
flaviviru
e
protein
green
quantif
infect
effici
viral
titer
releas
cultur
supernat
report
lower
two
panel
left
right
respect
scale
bar
mm
bar
graph
indic
mean
sem
field
includ
cell
independ
experi
p
valu
calcul
student
pair
ttest
interpret
refer
colour
figur
legend
reader
refer
web
version
articl
expand
vero
cell
titr
plaqu
form
assay
pfa
hamel
et
al
cell
seed
ml
well
plate
day
cultur
heparin
celsu
cincinnati
oh
ad
h
prior
infect
mgml
viruscontain
supernat
ad
provid
multipl
infect
moi
effici
infect
evalu
immunofluoresc
stain
either
antiflaviviru
envelop
monoclon
antibodi
mab
millipor
mab
doublestrand
rna
english
scientif
consult
kft
hungari
day
postinfect
evalu
apoptosi
ab
cell
signal
use
cell
wash
pb
incub
h
hoechst
either
antimous
alexa
antirabbit
alexa
secondari
ab
block
solut
thermofish
scientif
viral
supernat
collect
viral
titer
determin
pfa
cell
death
detect
ml
sampl
cultur
supernat
transfer
halfblack
microwel
plate
costar
well
ml
adenyl
kinas
detect
reagent
toxilight
bioassay
lonza
ad
plate
incub
min
room
temperatur
luminesc
measur
mithra
micropl
reader
berthold
technolog
immunofluoresc
stain
nestin
neuroectoderm
stem
cell
marker
transcript
factor
maintain
pluripot
selfrenew
confirm
natur
hnpc
employ
fig
upper
panel
hnpc
incub
heparin
mgml
h
prior
infect
see
supplementari
tabl
detail
heparin
character
supplementari
fig
h
c
nmr
spectra
histor
zikv
strain
recent
brazilian
strain
proport
infect
hnpc
ca
fig
middl
panel
modest
decreas
statist
signific
infect
cell
number
observ
cultur
pretreat
heparin
progeni
infecti
virion
product
measur
cultur
supernat
use
standard
pfa
vero
cell
indic
heparin
reduc
product
progeni
viru
fold
fig
lower
panel
next
evalu
effect
heparin
hnpc
infect
strain
character
lower
viru
replic
effici
nonetheless
antivir
effect
heparin
modest
statist
differ
untreat
cultur
determin
quantif
infect
effici
viral
titer
releas
cultur
supernat
pfa
vero
cell
fig
lower
panel
analyz
virusinduc
cytopath
effect
measur
level
adenyl
kinas
releas
cultur
supernat
damag
cell
membran
crouch
et
al
olsson
et
al
heparin
exert
toxic
effect
uninfect
cell
fig
unexpectedli
strikingli
howev
heparin
prevent
fulli
virusinduc
cytopath
effect
cultur
infect
either
zikv
strain
fig
b
respect
thu
heparin
partial
uncoupl
viru
replic
modestli
inhibit
virusinduc
death
hnpc
zikv
infect
cranial
neural
crest
cell
link
releas
vascular
endotheli
growth
factor
vegf
leukaemia
inhibitori
factor
lif
exert
proapoptot
effect
adjac
cell
bayless
et
al
thu
determin
proport
cell
posit
stain
indic
apoptot
cell
death
lavrik
proport
cell
uninfect
untreat
cell
cultur
increas
day
infect
day
initi
seed
day
infect
time
point
heparin
decreas
proport
cell
respect
infect
cultur
proport
cell
increas
day
postinfect
strain
decreas
treat
heparin
data
shown
result
suggest
activ
master
executor
apoptosi
ie
activ
hnpc
cultur
independ
viru
infect
heparin
probabl
prevent
activ
stabil
durat
cultur
report
caldwel
et
al
contrast
heparin
fulli
prevent
virusinduc
necrot
death
cell
measur
releas
adenyl
kinas
cultur
supernat
fig
although
mechan
action
remain
unknown
sinc
cultur
condit
induc
apoptosi
uninfect
hnpc
test
whether
heparin
affect
zikv
cytopath
effect
particular
prevent
activ
vero
cell
highli
permiss
zikv
replic
background
level
apoptosi
absenc
viral
infect
neglig
supplementari
fig
inde
heparin
treatment
alter
level
viral
replic
compar
control
vero
cell
howev
significantli
decreas
percentag
cell
suggest
heparin
also
prevent
zikvinduc
apoptosi
term
drug
repurpos
addit
inhibitor
cheng
et
al
et
al
heparin
repres
clinicallyapprov
pharmacolog
agent
capabl
prevent
zikvinduc
necrosi
neural
cell
observ
hnpc
lead
compound
help
discov
novel
agent
prevent
viru
replic
cytopath
effect
independ
obviou
heparin
anticoagul
effect
consider
evid
heparin
possess
antiinflammatori
antiapoptot
prolif
activ
reli
varieti
mechan
katsi
et
al
howev
polyanion
natur
heparin
favour
neutral
cation
mediat
inflamm
apoptosi
also
viral
envelop
rusnati
et
al
mechan
heparin
deriv
inhibit
infect
viral
infect
herp
simplex
viru
shukla
spear
like
compet
host
cell
surfac
glycoprotein
proteoglycan
case
bind
low
specif
sever
protein
virtu
polyanion
natur
present
case
howev
effect
heparin
infect
less
strike
abil
protect
infect
cell
cell
death
like
mechan
explain
phenomenon
heparin
bind
sever
protein
promot
inflamm
cell
death
heparin
document
bind
mani
case
neutralis
rang
relev
growth
factor
enzym
includ
tissu
necrosi
factora
tnfa
sala
et
al
spratt
et
al
veraldi
et
al
conclus
sinc
heparin
use
safe
pregnanc
could
serv
potenti
adjunct
therapi
presenc
likelihood
zikv
infect
ultralow
molecular
weight
heparin
report
cross
blood
brain
barrier
fda
guidelin
access
heparin
cross
placenta
http
htm
improv
deliveri
system
may
facilit
administr
heparin
heparin
deriv
